Examination of Plasma Concentrations and Safety in Chronic Kidney Disease Patients Undergoing Hemodialysis
Status:
Completed
Trial end date:
2013-06-26
Target enrollment:
Participant gender:
Summary
This study is to assess the safety, tolerability, plasma concentration and pharmacodynamics
of ASP7991 after oral administration to patients with chronic kidney disease undergoing
hemodialysis.